In vitro Evaluation of Antimicrobial Agents Susceptibility Against Several Clinical Isolates

임상 분리 균주의 항생제 감수성 유형

  • 최성숙 (삼육대학교 생명과학연구소, 삼육대학교 약학과) ;
  • 하남주 (삼육대학교 생명과학연구소, 삼육대학교 약학과)
  • Published : 1999.02.01

Abstract

In vitro activity of commonly used antimicrobial agents against several clinical isolates were studied. In the case of E. coli, the MICs at which 90% of the bacteria are inhibited of ampicillin, Unasyn, cefazoline, cefotaxim, carbenicillin, gentamicin and ofloxacin were 100<, 100, 25, 0.2, 100<, 3.13, and $12.5{\;}\mu\textrm{g}/m$ , respectively. In the case of K . pneumoniae, the MICs at which 90% of the bacteria are inhibited of ampicillin, Unasyn, crfazoline, cefotaxim, carbenicillin, gentamicin and ofloxacin were 100<, 12.5, 100<, 0.1, 100<, 1.6, and $0.4{\;}\mu\textrm{g}/m$ , respectively. In the case of Enterobacter sp, the MICs at which 90% of the bacteria are inhibited of ampicillin, Unasyn, cefazoline, cefotaxim, carbenicillin, gentamicin and ofloxacin were 100<, 100, 100<, 6.25, 100<, 100 and $1.57{\;}\mu\textrm{g}/m$ , respectively. In the case of Acinetobacter sp, the MICs at which 90% of the bacteria are inhibited of ampicillin, Unasyn, cefazoline, cefotaxim, carbenicillin, gentamicin and ofloxacin were 100<, 100<, 100<, 100<, 100< 100< and $50{\;}\mu\textrm{g}/m$ , respectively. In the case of Pseudomonas sp, the MICs at which 90% of the bacteria are inhibited of ampicillin, Unasyn, cefazoline, cefotaxim, carbenicillin, gentamicin and ofloxacin were 100<, 100<, 100<, 50, 100<, 25 and $25{\;}\mu\textrm{g}/m$, respectively. In the case of S. aureus, the MICs at which 90% of the bacteria are inhibited of ampicillin, Unasyn, cefazoline, cefotaxim, carbenicillin, gentamicin and ofloxacin were 50, 50, 100<, 100<, 50, 50, and $100{\;}\mu\textrm{g}/m$, respectively.

Keywords

References

  1. Inf. Dis. Clin. v.9 Principles of selection and use of antimicrobial agents Hessen, M. T.;Kage, D.
  2. Currentd therapy of infectious disease Schillossberg, D.
  3. Chemotherapy v.29 Committee report Japan Society of Chemotherapy
  4. Antimocrob. agents Chemother v.35 More extended-spectrum β-lactamase Jacoby, G. A.;Medeiros, A. A.
  5. Clin. Infect. Dis. v.22 Outbreak of Multiple resistant Enterobacteriaceae in an intensive care unit : epidemiology and risk factors for acqiusition Lucet, J.-C.;Chevret, S.;Decre'D.
  6. Ann. Intern. Med. v.119 Nosocomical outbreak of Klebsiella infection resistant to late generation cephalosporines Meyer, K. S.;Urbran, C.;Eagan, J. A.;Berger, B. J.;Rahal, J. J.